PRQR Covered Call Strategy
PRQR (ProQR Therapeutics N.V.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clinical trial to treat USH2A-mediated retinitis pigmentosa and usher syndrome. The company also engages in the developing of Axiomer RNA base-editing platform technology. It has a license agreement with Radboud University Medical Center, Inserm Transfert SA, Ionis Pharmaceuticals, Inc., and Leiden University Medical Center, as well as license and research collaboration with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. ProQR Therapeutics N.V. was incorporated in 2012 and is headquartered in Leiden, the Netherlands.
PRQR (ProQR Therapeutics N.V.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $179.1M, a beta of 0.07 versus the broader market, a 52-week range of 1.33-3.1, average daily share volume of 547K, a public-listing history dating back to 2014, approximately 166 full-time employees. These structural characteristics shape how PRQR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.07 indicates PRQR has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a covered call on PRQR?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
Current PRQR snapshot
As of May 15, 2026, spot at $1.60, ATM IV 25.70%, IV rank 1.58%, expected move 7.37%. The covered call on PRQR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this covered call structure on PRQR specifically: PRQR IV at 25.70% is on the cheap side of its 1-year range, which means a premium-selling PRQR covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 7.37% (roughly $0.12 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PRQR expiries trade a higher absolute premium for lower per-day decay. Position sizing on PRQR should anchor to the underlying notional of $1.60 per share and to the trader's directional view on PRQR stock.
PRQR covered call setup
The PRQR covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PRQR near $1.60, the first option leg uses a $1.68 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PRQR chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PRQR shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $1.60 | long |
| Sell 1 | Call | $1.68 | N/A |
PRQR covered call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
PRQR covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on PRQR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use covered call on PRQR
Covered calls on PRQR are an income strategy run on existing PRQR stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
PRQR thesis for this covered call
The market-implied 1-standard-deviation range for PRQR extends from approximately $1.48 on the downside to $1.72 on the upside. A PRQR covered call collects premium on an existing long PRQR position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether PRQR will breach that level within the expiration window. Current PRQR IV rank near 1.58% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on PRQR at 25.70%. As a Healthcare name, PRQR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PRQR-specific events.
PRQR covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PRQR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PRQR alongside the broader basket even when PRQR-specific fundamentals are unchanged. Short-premium structures like a covered call on PRQR carry tail risk when realized volatility exceeds the implied move; review historical PRQR earnings reactions and macro stress periods before sizing. Always rebuild the position from current PRQR chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on PRQR?
- A covered call on PRQR is the covered call strategy applied to PRQR (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With PRQR stock trading near $1.60, the strikes shown on this page are snapped to the nearest listed PRQR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are PRQR covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the PRQR covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 25.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a PRQR covered call?
- The breakeven for the PRQR covered call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PRQR market-implied 1-standard-deviation expected move is approximately 7.37%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on PRQR?
- Covered calls on PRQR are an income strategy run on existing PRQR stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current PRQR implied volatility affect this covered call?
- PRQR ATM IV is at 25.70% with IV rank near 1.58%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.